Team:UNIPV-Pavia/Calendar/July/settimana5
From 2010.igem.org
(→July, 29th) |
m (→July, 29th) |
||
(5 intermediate revisions not shown) | |||
Line 55: | Line 55: | ||
<table align='center'><tr><td> | <table align='center'><tr><td> | ||
- | [[Image:UNIPV10_I15_Extrabands.jpg|thumb| | + | [[Image:UNIPV10_I15_Extrabands.jpg|thumb|150px|center|4C5 (E-P) and I15-1 (E-P): extra-bands can be observed for I15-1]] |
</td><td> | </td><td> | ||
- | [[Image:UNIPV10_MC123_contaminants.jpg|thumb| | + | [[Image:UNIPV10_MC123_contaminants.jpg|thumb|150px|center|MC1-2-3 contaminants screening: no plasmid was observed]]</td></tr></table> |
<div align="right"><small>[[#indice|^top]]</small></div> | <div align="right"><small>[[#indice|^top]]</small></div> | ||
Line 63: | Line 63: | ||
==July, 27th== | ==July, 27th== | ||
- | Today we | + | Today we prepared I15-1 sample for sequencing. MiniPrep was performed on this culture and samples for both forward and reverse sequencing were prepared and sent to BMR genomics. |
Our self-inducible parts assembly goes on: we are ready to co-trasform I14_4C5, I16_4C5, I17_4C5, I18_4C5 and I19_4C5 in T9002 competent strain (home made). | Our self-inducible parts assembly goes on: we are ready to co-trasform I14_4C5, I16_4C5, I17_4C5, I18_4C5 and I19_4C5 in T9002 competent strain (home made). | ||
Line 133: | Line 133: | ||
* MC2: 34 ng/ul, digested with HindIII | * MC2: 34 ng/ul, digested with HindIII | ||
- | [[Image:UNIPV10_MC1_MC2_HindIII_and_unidigested_screening.jpg|thumb| | + | [[Image:UNIPV10_MC1_MC2_HindIII_and_unidigested_screening.jpg|thumb|150px|center|Screening for MC1 and MC2: digested with HindIII and undigested]] |
<div align="right"><small>[[#indice|^top]]</small></div> | <div align="right"><small>[[#indice|^top]]</small></div> | ||
Line 139: | Line 139: | ||
==July, 28th== | ==July, 28th== | ||
- | + | Today we received primers to modify PhaPs. We diluted primers to perform a PCR with them in order to mutagenize this BioBrick to get its prefix Standard/Silver compliant and suffix Silver compliant. | |
<div align="right"><small>[[#indice|^top]]</small></div> | <div align="right"><small>[[#indice|^top]]</small></div> | ||
==July, 29th== | ==July, 29th== | ||
- | |||
- | |||
- | |||
Today we performed PCR in order to amplify the phasin PhaP (<partinfo>BBa_K208001</partinfo>). Out primers are built to eliminate the stop codon from phasin and to give it the prefix and suffix we desire: | Today we performed PCR in order to amplify the phasin PhaP (<partinfo>BBa_K208001</partinfo>). Out primers are built to eliminate the stop codon from phasin and to give it the prefix and suffix we desire: | ||
*PhaP with prefix compliant to the <html><a href="http://partsregistry.org/partsdb/scars.cgi"><b>10 Standard</b></a> and suffix compliant to the <a href="http://partsregistry.org/partsdb/scars.cgi"><b>Silver Standard</b></a></html> | *PhaP with prefix compliant to the <html><a href="http://partsregistry.org/partsdb/scars.cgi"><b>10 Standard</b></a> and suffix compliant to the <a href="http://partsregistry.org/partsdb/scars.cgi"><b>Silver Standard</b></a></html> | ||
Line 175: | Line 172: | ||
*1 ul of MilliQ (negative control). | *1 ul of MilliQ (negative control). | ||
Transformed cells have been plated on Cm 12,5 ug/ml agar plates and incubated overnight at 37°C. | Transformed cells have been plated on Cm 12,5 ug/ml agar plates and incubated overnight at 37°C. | ||
- | |||
- | |||
<div align="right"><small>[[#indice|^top]]</small></div> | <div align="right"><small>[[#indice|^top]]</small></div> |
Latest revision as of 16:54, 24 October 2010
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|